Coronavirus updates: Pfizer vaccine reaches final review for FDA authorization as US nears 290K deaths
Pfizer’s coronavirus vaccine could become first to earn U.S. Food and Drug Administration authorization as early as Thursday. The 17-member independent Vaccines and Related Biological Products Advisory Committee will meet Thursday to review and discuss data from Pfizer and German startup BioNTech on their vaccine,
Read More